Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 2e-05 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |